Since its discovery in 1995, this type of hereditary cancer has changed from one type of cancer, caused by mutations in only one gene to several types of cancer, caused by mutations in any of many different genes. As a result, all labels used to describe this syndrome, such as ''breast cancer gene'', ''BRCA'', ''hereditary breast and ovarian cancer'' and ''HBOC'' tell only part of the story, leaving out well over half of those who are affected.  To better serve our patient group, we are in the process of changing our name and updating all resources to reflect the fully inclusive and future forward RISKY GENES™ brand.  We ask for your patience during this process.  

The American Urological Association has recognized the importance of genetic testing with regard to inherited prostate cancer and the need for early screening.  LEARN MORE

Hereditary breast cancer was first discovered in the mid 1990's with mutations in the BRCA1 and BRCA2 genes, which are responsible for tumor-suppression in certain parts of the body.   Today, researchers know mutations in these and other genes also cause prostate and some other types of cancer.  

Every person carries these genes, whether male or female, and both sexes can pass mutations in those genes to biological children at a rate of 50%. 

Average hereditary prostate cancer risk is not as high as hereditary breast or ovarian cancer but is still considerably higher than in the general population. Hereditary prostate cancer risk is often displayed in average ranges and varies, depending on the source.  Personal cancer risk must be assessed by a professional and is based on which gene is mutated, the type of mutation within that gene and a variety of other factors, including number of first-degree relatives with relevant types of cancer.  

​Hereditary prostate cancers tend to be more aggressive, so treatment may vary from those for the general population.  For example, The Journal of Clinical Oncology recommends immediate surgery of BRCA2 genetic prostate cancer.


To have evidence for prostate cancer risk and access to early prostate cancer screening

To have evidence for male breast, pancreas, melanoma and other related cancer risk and access to cancer screening  LEARN MORE

To have knowledge of increased cancer risk for children and other biological family members so they have the opportunity to make informed health decisions   LEARN MORE

If a partner is also a carrier, to have knowledge about increased risks to biological children for other health issues so decisions can be made that may include pre-implantation diagnosisFor example, a union between a BRCA2 carrier and another BRCA2 carrier may result in Fanconi Anemia  LEARN MORE

In the event of an hereditary cancer diagnosis, knowledge of an inherited mutation may alter the type of cancer treatment  LEARN MORE

No fee genetic testing is available through government health services but is dependent on certain criteria. Anyone can obtain genetic testing through certain private clinics and through affordable online services  LEARN MORE

Hereditary Prostate Cancer

Risky Genes cause higher Risk of prostate cancer in male carriers